919 related articles for article (PubMed ID: 15386591)
1. Latent and lytic Epstein-Barr virus replication strategies.
Tsurumi T; Fujita M; Kudoh A
Rev Med Virol; 2005; 15(1):3-15. PubMed ID: 15386591
[TBL] [Abstract][Full Text] [Related]
2. Lytic cycle switches of oncogenic human gammaherpesviruses.
Miller G; El-Guindy A; Countryman J; Ye J; Gradoville L
Adv Cancer Res; 2007; 97():81-109. PubMed ID: 17419942
[TBL] [Abstract][Full Text] [Related]
3. [Molecular mechanism of lytic phase of Epstein-Barr virus DNA replication].
Tsurumi T
Nihon Rinsho; 1997 Feb; 55(2):321-7. PubMed ID: 9046818
[TBL] [Abstract][Full Text] [Related]
4. Human p32: a coactivator for Epstein-Barr virus nuclear antigen-1-mediated transcriptional activation and possible role in viral latent cycle DNA replication.
Van Scoy S; Watakabe I; Krainer AR; Hearing J
Virology; 2000 Sep; 275(1):145-57. PubMed ID: 11017796
[TBL] [Abstract][Full Text] [Related]
5. Regulation and dysregulation of Epstein-Barr virus latency: implications for the development of autoimmune diseases.
Niller HH; Wolf H; Minarovits J
Autoimmunity; 2008 May; 41(4):298-328. PubMed ID: 18432410
[TBL] [Abstract][Full Text] [Related]
6. Induction of lytic Epstein-Barr virus (EBV) infection in EBV-associated malignancies using adenovirus vectors in vitro and in vivo.
Westphal EM; Mauser A; Swenson J; Davis MG; Talarico CL; Kenney SC
Cancer Res; 1999 Apr; 59(7):1485-91. PubMed ID: 10197618
[TBL] [Abstract][Full Text] [Related]
7. Architecture of replication compartments formed during Epstein-Barr virus lytic replication.
Daikoku T; Kudoh A; Fujita M; Sugaya Y; Isomura H; Shirata N; Tsurumi T
J Virol; 2005 Mar; 79(6):3409-18. PubMed ID: 15731235
[TBL] [Abstract][Full Text] [Related]
8. Immune activation suppresses initiation of lytic Epstein-Barr virus infection.
Ladell K; Dorner M; Zauner L; Berger C; Zucol F; Bernasconi M; Niggli FK; Speck RF; Nadal D
Cell Microbiol; 2007 Aug; 9(8):2055-69. PubMed ID: 17419714
[TBL] [Abstract][Full Text] [Related]
9. A molecular link between malaria and Epstein-Barr virus reactivation.
Chêne A; Donati D; Guerreiro-Cacais AO; Levitsky V; Chen Q; Falk KI; Orem J; Kironde F; Wahlgren M; Bejarano MT
PLoS Pathog; 2007 Jun; 3(6):e80. PubMed ID: 17559303
[TBL] [Abstract][Full Text] [Related]
10. Latency pattern of Epstein-Barr virus and methylation status in Epstein-Barr virus-associated hemophagocytic syndrome.
Yoshioka M; Kikuta H; Ishiguro N; Endo R; Kobayashi K
J Med Virol; 2003 Jul; 70(3):410-9. PubMed ID: 12767005
[TBL] [Abstract][Full Text] [Related]
11. Phosphorylation of MCM4 at sites inactivating DNA helicase activity of the MCM4-MCM6-MCM7 complex during Epstein-Barr virus productive replication.
Kudoh A; Daikoku T; Ishimi Y; Kawaguchi Y; Shirata N; Iwahori S; Isomura H; Tsurumi T
J Virol; 2006 Oct; 80(20):10064-72. PubMed ID: 17005684
[TBL] [Abstract][Full Text] [Related]
12. Amplification of the Kaposi's sarcoma-associated herpesvirus/human herpesvirus 8 lytic origin of DNA replication is dependent upon a cis-acting AT-rich region and an ORF50 response element and the trans-acting factors ORF50 (K-Rta) and K8 (K-bZIP).
AuCoin DP; Colletti KS; Cei SA; Papousková I; Tarrant M; Pari GS
Virology; 2004 Jan; 318(2):542-55. PubMed ID: 14972523
[TBL] [Abstract][Full Text] [Related]
13. Inhibition of nasopharyngeal carcinoma growth by RTA-expressing baculovirus vectors containing oriP.
Wang L; Shan L; Lo KW; Yin J; Zhang Y; Sun R; Zhong J
J Gene Med; 2008 Oct; 10(10):1124-33. PubMed ID: 18642396
[TBL] [Abstract][Full Text] [Related]
14. Epstein-Barr virus single-stranded DNA-binding protein: purification, characterization, and action on DNA synthesis by the viral DNA polymerase.
Tsurumi T; Kobayashi A; Tamai K; Yamada H; Daikoku T; Yamashita Y; Nishiyama Y
Virology; 1996 Aug; 222(2):352-64. PubMed ID: 8806519
[TBL] [Abstract][Full Text] [Related]
15. A concatenated form of Epstein-Barr viral DNA in lymphoblastoid cell lines induced by transfection with BZLF1.
Cho MS; Tran VM
Virology; 1993 Jun; 194(2):838-42. PubMed ID: 8389085
[TBL] [Abstract][Full Text] [Related]
16. Epstein-Barr virus BZLF1 gene, a switch from latency to lytic infection, is expressed as an immediate-early gene after primary infection of B lymphocytes.
Wen W; Iwakiri D; Yamamoto K; Maruo S; Kanda T; Takada K
J Virol; 2007 Jan; 81(2):1037-42. PubMed ID: 17079287
[TBL] [Abstract][Full Text] [Related]
17. Hypoxia can contribute to the induction of the Epstein-Barr virus (EBV) lytic cycle.
Jiang JH; Wang N; Li A; Liao WT; Pan ZG; Mai SJ; Li DJ; Zeng MS; Wen JM; Zeng YX
J Clin Virol; 2006 Oct; 37(2):98-103. PubMed ID: 16931136
[TBL] [Abstract][Full Text] [Related]
18. Interactions of Epstein-Barr virus origins of replication with nuclear matrix in the latent and in the lytic phases of viral infection.
Mattia E; Ceridono M; Chichiarelli S; D'Erme M
Virology; 1999 Sep; 262(1):9-17. PubMed ID: 10489336
[TBL] [Abstract][Full Text] [Related]
19. Lytic cycle gene regulation of Epstein-Barr virus.
Amon W; Binné UK; Bryant H; Jenkins PJ; Karstegl CE; Farrell PJ
J Virol; 2004 Dec; 78(24):13460-9. PubMed ID: 15564457
[TBL] [Abstract][Full Text] [Related]
20. Reactivation of Epstein-Barr virus from latency.
Amon W; Farrell PJ
Rev Med Virol; 2005; 15(3):149-56. PubMed ID: 15546128
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
